LUCD
HealthcareLucid Diagnostics Inc.
$1.13
+$0.01 (+0.89%)
Jan 5, 2026
Price History (1Y)
Analysis
Lucid Diagnostics Inc. operates in the healthcare sector, specifically within the medical devices industry. The company has a relatively small scale with 72 employees and a market capitalization of $148.14 million. The financial health of Lucid Diagnostics Inc. is marked by significant losses, with net income totaling -$65,844,000 over the trailing twelve months. The company's profitability metrics are negative across the board, including gross margin at -58.1%, operating margin at -971.0%, and profit margin at 0.0%. Returns on equity and assets are also negative, at -331.2% and -79.2%, respectively. The balance sheet shows a debt-to-equity ratio of 94.19 and cash reserves of $48.38 million. The valuation context for Lucid Diagnostics Inc. is characterized by low price metrics, with a forward P/E ratio of -3.73 and a price to sales ratio of 33.68. The company's revenue growth over the past year has been relatively modest at 3.3%, although earnings growth data is not available.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Lucid Diagnostics Inc.
Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. Its flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths through early detection of esophageal precancer in at-risk GERD patients. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. operates as a subsidiary of PAVmed Inc.
Visit website →Key Statistics
- Market Cap
- $148.14M
- P/E Ratio
- N/A
- 52-Week High
- $1.80
- 52-Week Low
- $0.80
- Avg Volume
- 816.54K
- Beta
- 1.22
Company Info
- Industry
- Medical Devices
- Exchange
- NCM
- Country
- United States
- Employees
- 72